4//SEC Filing
Alder Matthias 4
Accession 0001493152-24-011836
CIK 0001819411other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 9:00 PM ET
Size
16.3 KB
Accession
0001493152-24-011836
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-03-26+18,750→ 25,763 total - Exercise/Conversion
Common Stock
2024-03-26+825→ 26,588 total - Exercise/Conversion
Common Stock
2024-03-26+637→ 27,225 total - Tax Payment
Common Stock
2024-03-26$4.06/sh−6,085$24,705→ 21,140 total - Exercise/Conversion
Restricted Stock Units
2024-03-26−825→ 8,250 total→ Common Stock (249 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-26−637→ 6,376 total→ Common Stock (192 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-26−18,750→ 56,250 total→ Common Stock (18,750 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F4]The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001370820
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 9:00 PM ET
- Size
- 16.3 KB